Involvement of insulin-like growth factor type 1 receptor and protein kinase Cδ in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells

Biochemistry

Volumn 45, Issue 38, 2006, Pages 11605-11615

  Mehdi, Mohamad Z ^c   Vardatsikos, George ^c   Pandey, Sanjay K ^b   Srivastava, Ashok K ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b ISIS PHARMACEUTICALS   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CELLS; ENZYME KINETICS; GLUCOSE; INSULIN; MOLECULAR DYNAMICS;

MOLECULAR MECHANISM; PHOSPHATASES; PHOSPHORYLATION; PROTEIN TYROSINE KINASES (PTK);

ENZYMES;

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 6,7 DIMETHYL 2 PHENYLQUINOXALINE; ANTISENSE OLIGONUCLEOTIDE; BIS(MALTOLATO)OXOVANADIUM; CHELERYTHRINE; EPIDERMAL GROWTH FACTOR; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; ROTTLERIN; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL CELL; ARTICLE; CHO CELL; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; GLUCOSE METABOLISM; HEPATOMA CELL; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN KINASE C-DELTA; PROTO-ONCOGENE PROTEINS C-AKT; PYRONES; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TYRPHOSTINS; VANADATES;

EID: 33749039500     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi060403x     Document Type: Article

References (71)

1. Srivastava, A. K., and Mehdi, M. Z. (2005) Insulino-mimetic and anti-diabetic effects of vanadium compounds, Diabetes Med. 22, 2-13.
2. Pandey, S. K., Anand-Srivastava, M. B., and Srivastava, A. K. (1998) Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent of insulin receptor tyrosine phosphorylation, Biochemistry 37, 7006-7014.
3. Mehdi, M. Z., and Srivastava, A. K. (2005) Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: Mechanism of insulinomimesis, Arch. Biochem. Biophys. 440, 158-164.
4. Pandey, S. K., Theberge, J. F., Bernier, M., and Srivastava, A. K. (1999) Phosphatidylinositol 3-kinase requirement in activation of the ras/C-raf-1/MEK/ERK and p70(s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate, Biochemistry 38, 14667-14675.
5. Whiteman, E. L., Cho, H., and Birnbaum, M. J. (2002) Role of Akt/protein kinase B in metabolism, Trends Endocrinol. Metab. 13, 444-451.
6. Song, G., Ouyang, G., and Bao, S. (2005) The activation of Akt/PKB signaling pathway and cell survival, J. Cell. Mol. Med. 9, 59-71.
7. Yuen, V. G., Orvig, C., Thompson, K. H., and McNeill, J. H. (1993) Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV), Can. J. Physiol. Pharmacol. 71, 270-276.
8. Fujisawa, Y., and Sakurai, H. (1999) Evidence for the improvement of noninsulin-dependent diabetes mellitus in KKAy mice with daily oral administration of bis(6-methylpicolinato)oxovanadium(IV) complex, Chem. Pharm. Bull. 47, 1668-1670.
9. Reul, B. A., Amin, S. S., Buchet, J. P., Ongemba, L. N., Crans, D. C., and Brichard, S. M. (1999) Effects of vanadium complexes with organic ligands on glucose metabolism: A comparison study in diabetic rats, Br. J. Pharmacol. 126, 467-477.
10. Winter, C. L., Lange, J. S., Davis, M. G., Gerwe, G. S., Downs, T. R., Peters, K. G., and Kasibhatla, B. (2005) A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats, Exp. Biol. Med. (Maywood, NJ, U.S.) 230, 207-216.
11. Semiz, S., and McNeill, J. H. (2002) Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity, Mol. Cell. Biochem. 236, 123-131.
12. Mohammad, A., Wang, J., and McNeill, J. H. (2002) Bis(maltolato) oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo, Mol. Cell. Biochem. 229, 125-128.
13. Marzban, L., Rahimian, R., Brownsey, R. W., and McNeill, J. H. (2002) Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo, Endocrinology 143, 4636-4645.
14. Pugazhenthi, S., and Khandelwal, R. L. (1993) Does the insulin-mimetic action of vanadate involve insulin receptor kinase? Mol. Cell. Biochem. 127-128, 211-218.
15. Cordera, R., Andraghetti, G., DeFronzo, R. A., and Rossetti, L. (1990) Effect of in vivo vanadate treatment on insulin receptor tyrosine kinase activity in partially pancreatectomized diabetic rats, Endocrinology 126, 2177-2183.
16. Fantus, I. G., Kadota, S., Deragon, G., Foster, B., and Posner, B. I. (1989) Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase, Biochemistry 28, 8864-8871.
17. D'Onofrio, F., Le, M. Q., Chiasson, J. L., and Srivastava, A. K. (1994) Activation of mitogen activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylation, FEBS Lett. 340, 269-275.
18. Blondel, O., Simon, J., Chevalier, B., and Portha, B. (1990) Impaired insulin action but normal insulin receptor activity in diabetic rat liver: Efect of vanadate, Am. J. Physiol. 258, E459-E467.
19. Venkatesan, N., Avidan, A., and Davidson, M. B. (1991) Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity, Diabetes 40, 492-498.
20. Molero, J. C., Martinez, C., Andres, A., Satrustegui, J., and Carrascosa, J. M. (1998) Vanadate fully stimulates insulin receptor substrate-1 associated phosphatidyl inositol 3-kinase activity in adipocytes from young and old rats, FEBS Lett. 425, 298-304.
21. Bohula, E. A., Salisbury, A. J., Sohail, M., Playford, M. P., Riedemann, J., Southern, E. M., and Macaulay, V. M. (2003) The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript, J. Biol. Chem. 278, 15991-15997.
22. Kayali, A. G., Austin, D. A., and Webster, N. J. (2002) Rottlerin inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes by uncoupling mitochondrial oxidative phosphorylation, Endocrinology 143, 3884-3896.
23. Kaser, S., Foger, B., Ebenbichler, C. F., Kirchmair, R., Gander, R., Ritsch, A., Sandhofer, A., and Patsch, J. R. (2001) Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2, Int. J. Obes. Relat. Metab. Disord. 25, 1633-1639.
24. Chou, C. K., Dull, T. J., Russell, D. S., Gherzi, R., Lebwohl, D., Ullrich, A., and Rosen, O. M. (1987) Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin, J. Biol. Chem. 262, 1842-1847.
25. Kim, Y. R., Cha, H. Y., Lim, K., Hwang, B. D., Hoe, K. L., Namgung, U., and Park, S. K. (2003) Activation of epidermal growth factor receptor is responsible for pervanadate-induced phospholipase D activation, Exp. Mol. Med. 35, 118-124.
26. Wang, Y. Z., and Bonner, J. C. (2000) Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts, Am. J. Respir. Cell Mol. Biol. 22, 590-596.
27. Cruzado, M. C., Risler, N. R., Miatello, R. M., Yao, G., Schiffrin, E. L., and Touyz, R. M. (2005) Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation, Am. J. Hypertens. 18, 81-87.
28. Zahradka, P., Litchie, B., Storie, B., and Helwer, G. (2004) Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase, Endocrinology 145, 2978-2987.
29. Parrizas, M., Gazit, A., Levitzki, A., Wertheimer, E., and LeRoith, D. (1997) Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins, Endocrinology 138, 1427-1433.
30. Levitzki, A., and Gazit, A. (1995) Tyrosine kinase inhibition: An approach to drug development, Science 267, 1782-1788.
31. Kovalenko, M., Gazit, A., Bohmer, A., Rorsman, C., Ronnstrand, L., Heldin, C. H., Waltenberger, J., Bohmer, F. D., and Levitzki, A. (1994) Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation, Cancer Res. 54, 6106-6114.
32. 2 production requires the activation of phosphatidylinositol 3-kinase, J. Biol. Chem. 275, 10527-10531.
33. Brodt, P., Fallavollita, L., Khatib, A. M., Samani, A. A., and Zhang, D. (2001) Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor β subunit, J. Biol. Chem. 276, 33608-33615.
34. Ginnan, R., and Singer, H. A. (2005) PKC-δ-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle, Am. J. Physiol. 288, C1193-C1201.
35. Iwabu, A., Smith, K., Allen, F. D., Lauffenburger, D. A., and Wells, A. (2004) Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C δ-dependent pathway, J. Biol. Chem. 279, 14551-14560.
36. Shah, B. H., and Catt, K. J. (2002) Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: Roles of protein kinase Cδ, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation, Mol. Pharmacol. 61, 343-351.
37. Gliki, G., Wheeler-Jones, C., and Zachary, I. (2002) Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3′-kinase-mediates PKCδ phosphorylation: Role of PKC in angiogenesis, Cell Biol. Int. 26, 751-759.
38. Kuriyama, M., Taniguchi, T., Shirai, Y., Sasaki, A., Yoshimura, A., and Saito, N. (2004) Activation and translocation of PKCδ is necessary for VEGF-induced ERK activation through KDR in HEK293T cells, Biochem. Biophys. Res. Commun. 325, 843-851.
39. Olivares-Reyes, J. A., Shah, B. H., Hernandez-Aranda, J., Garcia-Caballero, A., Farshori, M. P., Garcia-Sainz, J. A., and Catt, K. J. (2005) Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors, Mol. Pharmacol. 68, 356-364.
40. 2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells, Antioxid. Redox Signaling 6, 353-366.
41. Steinberg, S. F. (2004) Distinctive activation mechanisms and functions for protein kinase Cδ, Biochem. J. 384, 449-459.
42. Soltoff, S. P. (2001) Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cδ tyrosine phosphorylation, J. Biol. Chem. 276, 37986-37992.
43. Benes, C., and Soltoff, S. P. (2001) Modulation of PKCδ tyrosine phosphorylation and activity in salivary and PC-12 cells by Src kinases, Am. J. Physiol. 280, C1498-C1510.
44. Rybin, V. O., Guo, J., Sabri, A., Elouardighi, H., Schaefer, E., and Steinberg, S. F. (2004) Stimulus-specific differences in protein kinase Cδ localization and activation mechanisms in cardiomyocytes, J. Biol. Chem. 279, 19350-19361.
45. Li, W., Jiang, Y. X., Zhang, J., Soon, L., Flechner, L., Kapoor, V., Pierce, J. H., and Wang, L. H. (1998) Protein kinase C-δ is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation, Mol. Cell. Biol. 18, 5888-5898.
46. Li, W., Mischak, H., Yu, J. C., Wang, L. M., Mushinski, J. F., Heidaran, M. A., and Pierce, J. H. (1994) Tyrosine phosphorylation of protein kinase C-δ in response to its activation, J. Biol. Chem. 269, 2349-2352.
47. Mohammad, A., Sharma, V., and McNeill, J. H. (2002) Vanadium increases GLUT4 in diabetic rat skeletal muscle, Mol. Cell. Biochem. 233, 139-143.
48. Touyz, R. M., Cruzado, M., Tabet, F., Yao, G., Salomon, S., and Schiffrin, E. L. (2003) Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: Role of receptor tyrosine kinase transactivation, Can. J. Physiol. Pharmacol. 81, 159-167.
49. Tabet, F., Schiffrin, E. L., and Touyz, R. M. (2005) Mitogen-activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase-dependent, protein kinase C-independent pathways in vascular smooth muscle cells: Upregulation in spontaneously hypertensive rats, J. Hypertens. 23, 2005-2012.
50. Van Kolen, K., Gilany, K., Moens, L., Esmans, E. L., and Slegers, H. (2005) P2Y(12) receptor signalling towards PKB proceeds through IGF-I receptor cross-talk and requires activation of Src, Pyk2 and Rap1, Cell Signaling 18, 1169-1181.
51. Yin, G., Yan, C., and Berk, B. C. (2003) Angiotensin II signaling pathways mediated by tyrosine kinases, Int. J. Biochem. Cell Biol. 35, 780-783.
52. Blakesley, V. A., Scrimgeour, A., Esposito, D., and Le Roith, D. (1996) Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling? Cytokine Growth Factor Rev. 7, 153-159.
53. Mehdi, M. Z., Pandey, S. K., Theberge, J. F., and Srivastava, A. K. (2006) Insulin Signal Mimicry as a Mechanism for the Insulin-Like Effects of Vanadium, Cell Biochem. Biophys. 44, 73-81.
54. Khandelwal, R. L., and Pugazhenthi, S. (1995) In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals, Mol. Cell. Biochem. 153, 87-94.
55. Skaletz-Rorowski, A., Eschert, H., Leng, J., Stallmeyer, B., Sindermann, J. R., Pulawski, E., and Breithardt, G. (2005) PKC δ-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells, Cardiovasc. Res. 67, 142-150.
56. Chintalgattu, V., and Katwa, L. C. (2004) Role of protein kinase Cδ in endothelin-induced type I collagen expression in cardiac myofibroblasts isolated from the site of myocardial infarction, J. Pharmacol. Exp. Ther. 311, 691-699.
57. Jackson, D., Zheng, Y., Lyo, D., Shen, Y., Nakayama, K., Nakayama, K. I., Humphries, M. J., Reyland, M. E., and Foster, D. A. (2005) Suppression of cell migration by protein kinase Cδ, Oncogene 24, 3067-3072.
58. Bandyopadhyay, G., Standaert, M. L., Sajan, M. P., Karnitz, L. M., Cong, L., Quon, M. J., and Farese, R. V. (1999) Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-ζ, Mol. Endocrinol. 13, 1766-1772.
59. Braiman, L., Alt, A., Kuroki, T., Ohba, M., Bak, A., Tennenbaum, T., and Sampson, S. R. (1999) Protein kinase Cδ mediates insulin-induced glucose transport in primary cultures of rat skeletal muscle, Mol. Endocrinol. 13, 2002-2012.
60. Chalfant, C. E., Ciaraldi, T. P., Watson, J. E., Nikoulina, S., Henry, R. R., and Cooper, D. R. (2000) Protein kinase Cθ expression is increased upon differentiation of human skeletal muscle cells: Dysregulation in type 2 diabetic patients and a possible role for protein kinase Cθ in insulin-stimulated glycogen synthase activity, Endocrinology 141, 2773-2778.
61. Shen, S., Alt, A., Wertheimer, E., Gartsbein, M., Kuroki, T., Ohba, M., Braiman, L., Sampson, S. R., and Tennenbaum, T. (2001) PKCδ activation: A divergence point in the signaling of insulin and IGF-1-induced proliferation of skin keratinocytes, Diabetes 50, 255-264.
62. Caruso, M., Miele, C., Oriente, F., Maitan, A., Bifulco, G., Andreozzi, F., Condorelli, G., Formisano, P., and Beguinot, F. (1999) In L6 skeletal muscle cells, glucose induces cytosolic translocation of protein kinase C-α and trans-activates the insulin receptor kinase, J. Biol. Chem. 274, 28637-28644.
63. Formisano, P., Oriente, F., Miele, C., Caruso, M., Auricchio, R., Vigliotta, G., Condorelli, G., and Beguinot, F. (1998) In NIH-3T3 fibroblasts, insulin receptor interaction with specific protein kinase C isoforms controls receptor intracellular routing, J. Biol. Chem. 273, 13197-13202.
64. Davies, S. P., Reddy, H., Caivano, M., and Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J. 351, 95-105.
65. Song, J. S., Swann, P. G., Szallasi, Z., Blank, U., Blumberg, P. M., and Rivera, J. (1998) Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-δ with Src family kinases in the RBL-2H3 mast cell line: Regulation of Src family kinase activity by protein kinase C-δ, Oncogene 16, 3357-3368.
66. Li, W., Zhang, J., Flechner, L., Hyun, T., Yam, A., Franke, T. F., and Pierce, J. H. (1999) Protein kinase C-α overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal, Oncogene 18, 6564-6572.
67. Mao, M., Fang, X., Lu, Y., LaPushin, R., Bast, R. C., Jr., and Mills, G. B. (2000) Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells, Biochem. J. 352 (Part 2), 475-482.
68. Wen, H. C., Huang, W. C., Ali, A., Woodgett, J. R., and Lin, W. W. (2003) Negative regulation of phosphatidylinositol 3-kinase and Akt signalling pathway by PKC, Cell. Signalling 15, 37-45.
69. Dekker, L. V., and Parker, P. J. (1994) Protein kinase C: A question of specificity, Trends Biochem. Sci. 19, 73-77.
70. Andre, F., Rigot, V., Remacle-Bonnet, M., Luis, J., Pommier, G., and Marvaldi, J. (1999) Protein kinases C-γ and -δ are involved in insulin-like growth factor I-induced migration of colonic epithelial cells, Gastroenterologe 116, 64-77.
71. Yano, K., Bauchat, J. R., Liimatta, M. B., Clemmons, D. R., and Duan, C. (1999) Down-regulation of protein kinase C inhibits insulin-like growth factor I-induced vascular smooth muscle cell proliferation, migration, and gene expression, Endocrinology 140, 4622-4632.